{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:47:07Z","timestamp":1792090027680,"version":"4.4.0"},"reference-count":169,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bbcan.2020.188432","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T04:11:27Z","timestamp":1600402287000},"page":"188432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Targeting protein tyrosine kinase 6 in cancer"],"prefix":"10.1016","volume":"1874","author":[{"given":"Milica B.","family":"Gilic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela L.","family":"Tyner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bbcan.2020.188432_bb0005","first-page":"3403","article-title":"A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes","volume":"8","author":"Lee","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2020.188432_bb0010","first-page":"2383","article-title":"Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumours","volume":"9","author":"Mitchell","year":"1994","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.bbcan.2020.188432_bb0015","first-page":"2053","article-title":"Tyrosine kinase gene expression in the mouse small intestine","volume":"9","author":"Siyanova","year":"1994","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bbcan.2020.188432_bb0020","first-page":"349","article-title":"A novel intracellular epithelial cell tyrosine kinase is expressed in the skin and gastrointestinal tract","volume":"10","author":"Vasioukhin","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2020.188432_bb0025","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ijc.2910540409","article-title":"Novel protein kinases expresed in human breast cancer","volume":"54","author":"Cance","year":"1993","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2020.188432_bb0030","first-page":"1347","article-title":"Rak, a novel nuclear tyrosine kinase expressed in epithelial cells","volume":"5","author":"Cance","year":"1994","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.bbcan.2020.188432_bb0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0378-1119(94)90817-6","article-title":"Cloning of FRK, a novel human intracellular SRC-like tyrosine kinase-encoding gene","volume":"138","author":"Lee","year":"1994","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.bbcan.2020.188432_bb0040","first-page":"6915","article-title":"A novel nonreceptor tyrosine kinase, Srm: cloning and targeted disruption","volume":"14","author":"Kohmura","year":"1994","journal-title":"Mol. Cell. Biol."},{"issue":"9","key":"10.1016\/j.bbcan.2020.188432_bb0045","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/molbev\/msn132","article-title":"Gene expansion and retention leads to a diverse tyrosine kinase superfamily in amphioxus","volume":"25","author":"D\u2019Aniello","year":"2008","journal-title":"Mol. Biol. Evol."},{"issue":"6\u201310","key":"10.1016\/j.bbcan.2020.188432_bb0050","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3727\/096504003108748438","article-title":"Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases","volume":"13","author":"Serfas","year":"2003","journal-title":"Oncol. Res."},{"issue":"3\u20134","key":"10.1016\/j.bbcan.2020.188432_bb0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000134595","article-title":"Assignment of the human PTK6 gene encoding a non-receptor protein tyrosine kinase to 20q13.3 by fluorescence in situ hybridization","volume":"77","author":"Park","year":"1997","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.bbcan.2020.188432_bb0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13034-016-0121-8","article-title":"A boy with conduct disorder (CD), attention deficit hyperactivity disorder (ADHD), borderline intellectual disability, and 47,XXY syndrome in combination with a 7q11.23 duplication, 11p15.5 deletion, and 20q13.33 deletion","volume":"10","author":"Kolaitis","year":"2016","journal-title":"Child Adolesc. Psychiatry Ment. Health"},{"issue":"6","key":"10.1016\/j.bbcan.2020.188432_bb0065","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1073\/pnas.91.6.2156","article-title":"Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization","volume":"91","author":"Kallioniemi","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0070","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/cncr.11482","article-title":"Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis","volume":"98","author":"Zhao","year":"2003","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2020.188432_bb0075","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4161\/cbt.5.9.2953","article-title":"The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary","volume":"5","author":"Schmandt","year":"2006","journal-title":"Cancer Biol. Ther."},{"issue":"34","key":"10.1016\/j.bbcan.2020.188432_bb0080","doi-asserted-by":"crossref","first-page":"12463","DOI":"10.1073\/pnas.0805009105","article-title":"Brk is coamplified with ErbB2 to promote proliferation in breast cancer","volume":"105","author":"Xiang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2020.188432_bb0085","first-page":"4252","article-title":"Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets","volume":"130","author":"Paul","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188432_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014789","article-title":"The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of beta-catenin","volume":"6","author":"Brauer","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.bbcan.2020.188432_bb0095","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/sj.onc.1201292","article-title":"Characterisation and chromosome mapping of the human non receptor tyrosine kinase gene, brk","volume":"15","author":"Mitchell","year":"1997","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.bbcan.2020.188432_bb0100","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1128\/MCB.01206-14","article-title":"Brk\/protein tyrosine kinase 6 phosphorylates p27KIP1, regulating the activity of cyclin D-cyclin-dependent kinase 4","volume":"35","author":"Patel","year":"2015","journal-title":"Mol. Cell. Biol."},{"issue":"26","key":"10.1016\/j.bbcan.2020.188432_bb0105","doi-asserted-by":"crossref","first-page":"15934","DOI":"10.1074\/jbc.M115.651703","article-title":"Protein-tyrosine phosphatase and kinase specificity in regulation of SRC and breast tumor kinase","volume":"290","author":"Fan","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bbcan.2020.188432_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124233","article-title":"Structure, function, and regulation of the SRMS tyrosine kinase","volume":"21","author":"McClendon","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bbcan.2020.188432_bb0115","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1038\/sj.onc.1207339","article-title":"Role of the Brk SH3 domain in substrate recognition","volume":"23","author":"Qiu","year":"2004","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bbcan.2020.188432_bb0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbrc.2009.04.103","article-title":"Structural basis of the auto-inhibition mechanism of nonreceptor tyrosine kinase PTK6","volume":"384","author":"Ko","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"16","key":"10.1016\/j.bbcan.2020.188432_bb0125","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1128\/MCB.20.16.6114-6126.2000","article-title":"Sik (BRK) phosphorylates Sam68 in the nucleus and negatively regulates its RNA binding ability","volume":"20","author":"Derry","year":"2000","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188432_bb0130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/A:1011221125013","article-title":"Complete sequence-specific 1H, 13C and 15N resonance assignments of the human PTK6 SH2 domain","volume":"19","author":"Hong","year":"2001","journal-title":"J. Biomol. NMR"},{"issue":"28","key":"10.1016\/j.bbcan.2020.188432_bb0135","doi-asserted-by":"crossref","first-page":"29700","DOI":"10.1074\/jbc.M313185200","article-title":"Solution structure and backbone dynamics of the non-receptor protein-tyrosine kinase-6 Src homology 2 domain","volume":"279","author":"Hong","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molcel.2016.01.027","article-title":"SH2 domains serve as lipid-binding modules for pTyr-signaling proteins","volume":"62","author":"Park","year":"2016","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2020.188432_bb0145","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bbrc.2016.07.121","article-title":"Crystal structure of the kinase domain of human protein tyrosine kinase 6 (PTK6) at 2.33 \u00c5 resolution","volume":"478","author":"Thakur","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.bbcan.2020.188432_bb0150","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nsmb.1486","article-title":"Activation of tyrosine kinases by mutation of the gatekeeper threonine","volume":"15","author":"Azam","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2020.188432_bb0155","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.bbrc.2016.12.030","article-title":"Co-crystal structures of PTK6: With Dasatinib at 2.24 \u00c5, with novel imidazo[1,2-a]pyrazin-8-amine derivative inhibitor at 1.70 \u00c5 resolution","volume":"482","author":"Thakur","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"48","key":"10.1016\/j.bbcan.2020.188432_bb0160","doi-asserted-by":"crossref","first-page":"30956","DOI":"10.1074\/jbc.271.48.30956","article-title":"Brk, a breast tumor-derived non-receptor protein-tyrosine kinase, sensitizes mammary epithelial cells to epidermal growth factor","volume":"271","author":"Kamalati","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"37","key":"10.1016\/j.bbcan.2020.188432_bb0165","doi-asserted-by":"crossref","first-page":"34634","DOI":"10.1074\/jbc.M203877200","article-title":"Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition","volume":"277","author":"Qiu","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bbcan.2020.188432_bb0170","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1021\/pr100773t","article-title":"Comparative analysis of human SRC-family kinase substrate specificity in vitro","volume":"9","author":"Takeda","year":"2010","journal-title":"J. Proteome Res."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188432_bb0175","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ncb3295","article-title":"The LINK-A lncRNA activates normoxic HIF1alpha signalling in triple-negative breast cancer","volume":"18","author":"Lin","year":"2016","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0180","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1021\/cc7001217","article-title":"Solid-phase peptide library synthesis on HiCore resin for screening substrate specificity of Brk protein tyrosine kinase","volume":"10","author":"Shin","year":"2008","journal-title":"J. Comb. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0185","first-page":"66","article-title":"Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK","volume":"1806","author":"Brauer","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"20","key":"10.1016\/j.bbcan.2020.188432_bb0190","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1021\/acs.biochem.5b00303","article-title":"Cancer-associated mutations in breast tumor kinase\/PTK6 differentially affect enzyme activity and substrate recognition","volume":"54","author":"Tsui","year":"2015","journal-title":"Biochemistry"},{"issue":"269","key":"10.1016\/j.bbcan.2020.188432_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"issue":"5","key":"10.1016\/j.bbcan.2020.188432_bb0200","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"D1","key":"10.1016\/j.bbcan.2020.188432_bb0205","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188432_bb0210","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0167-4781(02)00234-8","article-title":"Characterization of the 5\u2032-flanking region of the human PTK6 gene","volume":"1574","author":"Kang","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bbcan.2020.188432_bb0215","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1158\/1541-7786.MCR-14-0384-T","article-title":"RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival","volume":"13","author":"Yu","year":"2015","journal-title":"Mol. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188432_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119148","article-title":"Sphingosine-1-phosphate induces the migration of thyroid follicular carcinoma cells through the microRNA-17\/PTK6\/ERK1\/2 pathway","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.bbcan.2020.188432_bb0225","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1158\/0008-5472.CAN-13-0523","article-title":"Breast tumor kinase (Brk\/PTK6) is a mediator of hypoxia-associated breast cancer progression","volume":"73","author":"Regan Anderson","year":"2013","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bbcan.2020.188432_bb0230","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1158\/1541-7786.MCR-18-0410","article-title":"Taxol induces Brk-dependent prosurvival phenotypes in TNBC cells through an AhR\/GR\/HIF-driven signaling axis","volume":"16","author":"Regan Anderson","year":"2018","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0235","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12885-018-5186-8","article-title":"Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells","volume":"19","author":"Miah","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2020.188432_bb0240","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41523-017-0047-1","article-title":"PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells","volume":"3","author":"Ito","year":"2017","journal-title":"NPJ Breast Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2020.188432_bb0245","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.gastro.2009.05.054","article-title":"Induction of protein tyrosine kinase 6 in mouse intestinal crypt epithelial cells promotes DNA damage-induced apoptosis","volume":"137","author":"Haegebarth","year":"2009","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.bbcan.2020.188432_bb0250","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1158\/1535-7163.MCT-12-0009","article-title":"Targeting protein tyrosine kinase 6 enhances apoptosis of colon cancer cells following DNA damage","volume":"11","author":"Gierut","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"10","key":"10.1016\/j.bbcan.2020.188432_bb0255","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1038\/jid.2015.166","article-title":"Protein tyrosine kinase 6 regulates UVB-induced signaling and tumorigenesis in mouse skin","volume":"135","author":"Chastkofsky","year":"2015","journal-title":"J. Investig. Dermatol."},{"issue":"4","key":"10.1016\/j.bbcan.2020.188432_bb0260","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1053\/j.gastro.2011.06.071","article-title":"Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane","volume":"141","author":"Gierut","year":"2011","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.bbcan.2020.188432_bb0265","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1158\/1541-7786.MCR-15-0034","article-title":"PTK6 potentiates gemcitabine-induced apoptosis by prolonging S-phase and enhancing DNA damage in pancreatic cancer","volume":"13","author":"Ono","year":"2015","journal-title":"Mol. Cancer Res. MCR"},{"issue":"20","key":"10.1016\/j.bbcan.2020.188432_bb0270","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1038\/s41388-020-1275-7","article-title":"Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression","volume":"39","author":"Chandrashekar","year":"2020","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.bbcan.2020.188432_bb0275","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1158\/0008-5472.CAN-06-3409","article-title":"Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells","volume":"67","author":"Ostrander","year":"2007","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0280","doi-asserted-by":"crossref","first-page":"9776","DOI":"10.1038\/s41598-019-46170-3","article-title":"MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells","volume":"9","author":"Cagle","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bbcan.2020.188432_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154351","article-title":"TNF\u03b1\/IFN\u03b3 mediated intestinal epithelial barrier dysfunction is attenuated by MicroRNA-93 downregulation of PTK6 in mouse colonic epithelial cells","volume":"11","author":"Haines","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbcan.2020.188432_bb0290","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2016.01.037","article-title":"MicroRNA-187, a downstream effector of TGFbeta pathway, suppresses Smad-mediated epithelial-mesenchymal transition in colorectal cancer","volume":"373","author":"Zhang","year":"2016","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.bbcan.2020.188432_bb0295","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/jid.2014.479","article-title":"miR-214 as a key hub that controls cancer networks: small player, multiple functions","volume":"135","author":"Penna","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.bbcan.2020.188432_bb0300","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3892\/mmr.2017.6203","article-title":"Overexpression of miR214 promotes the progression of human osteosarcoma by regulating the Wnt\/betacatenin signaling pathway","volume":"15","author":"Zhu","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"18","key":"10.1016\/j.bbcan.2020.188432_bb0305","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1016\/j.ejca.2013.07.149","article-title":"miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway","volume":"49","author":"Wang","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2020.188432_bb0310","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1042\/BJ20120803","article-title":"Hsp90 rescues PTK6 from proteasomal degradation in breast cancer cells","volume":"447","author":"Kang","year":"2012","journal-title":"Biochem. J."},{"issue":"10","key":"10.1016\/j.bbcan.2020.188432_bb0315","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.4161\/cbt.29822","article-title":"HIF-1alpha-independent hypoxia-induced rapid PTK6 stabilization is associated with increased motility and invasion","volume":"15","author":"Pires","year":"2014","journal-title":"Cancer Biol. Ther."},{"issue":"9","key":"10.1016\/j.bbcan.2020.188432_bb0320","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.cellsig.2013.05.010","article-title":"HER2 regulates Brk\/PTK6 stability via upregulating calpastatin, an inhibitor of calpain","volume":"25","author":"Ai","year":"2013","journal-title":"Cell. Signal."},{"issue":"34","key":"10.1016\/j.bbcan.2020.188432_bb0325","doi-asserted-by":"crossref","first-page":"24923","DOI":"10.1074\/jbc.M113.482737","article-title":"Protein-tyrosine phosphatase 1B antagonized signaling by insulin-like growth factor-1 receptor and kinase BRK\/PTK6 in ovarian cancer cells","volume":"288","author":"Fan","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0330","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41467-017-01574-5","article-title":"PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer","volume":"8","author":"Wozniak","year":"2017","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.bbcan.2020.188432_bb0335","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1158\/0008-5472.CAN-13-0443","article-title":"PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer","volume":"73","author":"Zheng","year":"2013","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.bbcan.2020.188432_bb0340","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1128\/MCB.24.24.10558-10572.2004","article-title":"Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin","volume":"24","author":"Chen","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"17","key":"10.1016\/j.bbcan.2020.188432_bb0345","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1128\/MCB.00024-10","article-title":"Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor","volume":"30","author":"Zheng","year":"2010","journal-title":"Mol. Cell. Biol."},{"issue":"26","key":"10.1016\/j.bbcan.2020.188432_bb0350","doi-asserted-by":"crossref","first-page":"14477","DOI":"10.1073\/pnas.94.26.14477","article-title":"A role for the epithelial-cell-specific tyrosine kinase Sik during keratinocyte differentiation","volume":"94","author":"Vasioukhin","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0355","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1158\/0008-5472.CAN-07-2126","article-title":"Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms","volume":"68","author":"Chakraborty","year":"2008","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.bbcan.2020.188432_bb0360","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.4161\/cc.9.20.13518","article-title":"Cytoplasmic retention of protein tyrosine kinase 6 promotes growth of prostate tumor cells","volume":"9","author":"Brauer","year":"2010","journal-title":"Cell Cycle"},{"issue":"36","key":"10.1016\/j.bbcan.2020.188432_bb0365","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1038\/onc.2012.427","article-title":"Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT","volume":"32","author":"Zheng","year":"2013","journal-title":"Oncogene"},{"issue":"Pt 2","key":"10.1016\/j.bbcan.2020.188432_bb0370","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1242\/jcs.053264","article-title":"Identification of beta-catenin as a target of the intracellular tyrosine kinase PTK6","volume":"123","author":"Palka-Hamblin","year":"2010","journal-title":"J. Cell Sci."},{"issue":"27","key":"10.1016\/j.bbcan.2020.188432_bb0375","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1038\/sj.onc.1206465","article-title":"Altered localization and activity of the intracellular tyrosine kinase BRK\/Sik in prostate tumor cells","volume":"22","author":"Derry","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0380","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jb\/mvp050","article-title":"Oncogenic functions of PTK6 are enhanced by its targeting to plasma membrane but abolished by its targeting to nucleus","volume":"146","author":"Ie Kim","year":"2009","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbcan.2020.188432_bb0385","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13665-6","article-title":"PSPC1-interchanged interactions with PTK6 and beta-catenin synergize oncogenic subcellular translocations and tumor progression","volume":"10","author":"Lang","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188432_bb0390","doi-asserted-by":"crossref","first-page":"1721253","DOI":"10.1080\/23723556.2020.1721253","article-title":"PSPC1: a contextual determinant of tumor progression","volume":"7","author":"Lang","year":"2020","journal-title":"Mol. Cell Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2020.188432_bb0395","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.bjc.6604660","article-title":"Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients","volume":"99","author":"Aubele","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"48","key":"10.1016\/j.bbcan.2020.188432_bb0400","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1038\/sj.onc.1203931","article-title":"Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation","volume":"19","author":"Kamalati","year":"2000","journal-title":"Oncogene"},{"issue":"40","key":"10.1016\/j.bbcan.2020.188432_bb0405","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1038\/onc.2011.608","article-title":"Brk\/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR","volume":"31","author":"Li","year":"2012","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.bbcan.2020.188432_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011729","article-title":"PTK6 regulates IGF-1-induced anchorage-independent survival","volume":"5","author":"Irie","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bbcan.2020.188432_bb0415","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/bcr2622","article-title":"Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells","volume":"12","author":"Castro","year":"2010","journal-title":"Breast Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2020.188432_bb0420","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12672-011-0097-z","article-title":"Mechanisms of HGF\/Met signaling to Brk and Sam68 in breast cancer progression","volume":"3","author":"Locatelli","year":"2012","journal-title":"Horm Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2020.188432_bb0425","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1002\/jcb.25939","article-title":"PTK6 localized at the plasma membrane promotes cell proliferation and migration through phosphorylation of Eps8","volume":"118","author":"Shin","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"46","key":"10.1016\/j.bbcan.2020.188432_bb0430","doi-asserted-by":"crossref","first-page":"38639","DOI":"10.1074\/jbc.M505802200","article-title":"Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression","volume":"280","author":"Lukong","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"52","key":"10.1016\/j.bbcan.2020.188432_bb0435","doi-asserted-by":"crossref","first-page":"54398","DOI":"10.1074\/jbc.M409579200","article-title":"The nuclear tyrosine kinase BRK\/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2","volume":"279","author":"Haegebarth","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0440","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1128\/MCB.23.1.92-103.2003","article-title":"Sam68 enhances the cytoplasmic utilization of intron-containing RNA and is functionally regulated by the nuclear kinase Sik\/BRK","volume":"23","author":"Coyle","year":"2003","journal-title":"Mol. Cell. Biol."},{"issue":"9","key":"10.1016\/j.bbcan.2020.188432_bb0445","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.cellsig.2009.04.008","article-title":"BRK phosphorylates PSF promoting its cytoplasmic localization and cell cycle arrest","volume":"21","author":"Lukong","year":"2009","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188432_bb0450","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.cellsig.2007.11.003","article-title":"Breast tumor kinase BRK requires kinesin-2 subunit KAP3A in modulation of cell migration","volume":"20","author":"Lukong","year":"2008","journal-title":"Cell. Signal."},{"issue":"35","key":"10.1016\/j.bbcan.2020.188432_bb0455","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1038\/sj.onc.1209501","article-title":"Identification of STAT3 as a specific substrate of breast tumor kinase","volume":"25","author":"Liu","year":"2006","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bbcan.2020.188432_bb0460","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/bcr1794","article-title":"Signal transducer and activator of transcription 5b: a new target of breast tumor kinase\/protein tyrosine kinase 6","volume":"9","author":"Weaver","year":"2007","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbcan.2020.188432_bb0465","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.isci.2018.03.023","article-title":"Transcriptional co-activator functions of YAP and TAZ are inversely regulated by tyrosine phosphorylation status of parafibromin","volume":"2","author":"Tang","year":"2018","journal-title":"iScience"},{"key":"10.1016\/j.bbcan.2020.188432_bb0470","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.210","article-title":"Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse","volume":"6","author":"Peng","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2020.188432_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms12887","article-title":"Dephosphorylated parafibromin is a transcriptional coactivator of the Wnt\/Hedgehog\/Notch pathways","volume":"7","author":"Kikuchi","year":"2016","journal-title":"Nat. Commun."},{"issue":"37","key":"10.1016\/j.bbcan.2020.188432_bb0480","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1038\/sj.onc.1203775","article-title":"A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK","volume":"19","author":"Mitchell","year":"2000","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0485","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bbrc.2009.04.076","article-title":"STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation","volume":"384","author":"Ikeda","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0490","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1074\/jbc.M111.298117","article-title":"Protein-tyrosine kinase 6 promotes peripheral adhesion complex formation and cell migration by phosphorylating p130 CRK-associated substrate","volume":"287","author":"Zheng","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188432_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087684","article-title":"BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration","volume":"9","author":"Miah","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bbcan.2020.188432_bb0500","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1349-7006.2010.01842.x","article-title":"Involvement of STAP-2 in Brk-mediated phosphorylation and activation of STAT5 in breast cancer cells","volume":"102","author":"Ikeda","year":"2011","journal-title":"Cancer Sci."},{"issue":"49","key":"10.1016\/j.bbcan.2020.188432_bb0505","doi-asserted-by":"crossref","first-page":"38093","DOI":"10.1074\/jbc.M110.162388","article-title":"Interactions of STAP-2 with Brk and STAT3 participate in cell growth of human breast cancer cells","volume":"285","author":"Ikeda","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188432_bb0510","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/1541-7786.MCR-17-0602","article-title":"Dual inhibition of CDK4 and CDK2 via targeting p27 tyrosine phosphorylation induces a potent and durable response in breast cancer cells","volume":"16","author":"Patel","year":"2018","journal-title":"Mol. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2020.188432_bb0515","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1158\/1535-7163.MCT-18-0862","article-title":"Vemurafenib inhibits active PTK6 in PTEN-null prostate tumor cells","volume":"18","author":"Wozniak","year":"2019","journal-title":"Mol. Cancer Ther."},{"issue":"19","key":"10.1016\/j.bbcan.2020.188432_bb0520","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1158\/0008-5472.CAN-08-0997","article-title":"Breast tumor kinase phosphorylates p190RhoGAP to regulate rho and ras and promote breast carcinoma growth, migration, and invasion","volume":"68","author":"Shen","year":"2008","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0525","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13148-019-0764-4","article-title":"Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome","volume":"11","author":"Bucher-Johannessen","year":"2019","journal-title":"Clin. Epigenetics"},{"issue":"2","key":"10.1016\/j.bbcan.2020.188432_bb0530","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00001813-200402000-00002","article-title":"The Brk protein tyrosine kinase as a therapeutic target in cancer: opportunities and challenges","volume":"15","author":"Harvey","year":"2004","journal-title":"Anti-Cancer Drugs"},{"issue":"36","key":"10.1016\/j.bbcan.2020.188432_bb0535","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1038\/sj.onc.1208721","article-title":"Interaction between Brk kinase and insulin receptor substrate-4","volume":"24","author":"Qiu","year":"2005","journal-title":"Oncogene"},{"issue":"32","key":"10.1016\/j.bbcan.2020.188432_bb0540","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1038\/sj.onc.1206577","article-title":"Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation","volume":"22","author":"Harvey","year":"2003","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bbcan.2020.188432_bb0545","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/1541-7786.MCR-15-0450","article-title":"Kinase-dependent and \u2013independent roles for PTK6 in colon cancer","volume":"14","author":"Mathur","year":"2016","journal-title":"Mol. Cancer Res. MCR"},{"issue":"7","key":"10.1016\/j.bbcan.2020.188432_bb0550","first-page":"1767","article-title":"BRK\/Sik expression in the gastrointestinal tract and in colon tumors","volume":"5","author":"Llor","year":"1999","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.bbcan.2020.188432_bb0555","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.oraloncology.2004.05.010","article-title":"Differential expression of the non-receptor tyrosine kinase BRK in oral squamous cell carcinoma and normal oral epithelium","volume":"40","author":"Petro","year":"2004","journal-title":"Oral Oncol."},{"issue":"13","key":"10.1016\/j.bbcan.2020.188432_bb0560","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1128\/MCB.01901-05","article-title":"Protein tyrosine kinase 6 negatively regulates growth and promotes enterocyte differentiation in the small intestine","volume":"26","author":"Haegebarth","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188432_bb0565","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-2133.2005.06604.x","article-title":"Role of breast tumour kinase in the in vitro differentiation of HaCaT cells","volume":"153","author":"Wang","year":"2005","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.bbcan.2020.188432_bb0570","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/eci.12050","article-title":"Context-specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer","volume":"43","author":"Zheng","year":"2013","journal-title":"Eur. J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.bbcan.2020.188432_bb0575","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2353\/ajpath.2006.050521","article-title":"Expression and oncogenic role of Brk (PTK6\/Sik) protein tyrosine kinase in lymphocytes","volume":"168","author":"Kasprzycka","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.bbcan.2020.188432_bb0580","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1186\/bcr2946","article-title":"Mammary gland specific expression of Brk\/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK","volume":"13","author":"Lofgren","year":"2011","journal-title":"Breast Cancer Res. BCR"},{"issue":"15","key":"10.1016\/j.bbcan.2020.188432_bb0585","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.18632\/oncotarget.2153","article-title":"PTK6\/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors","volume":"5","author":"Peng","year":"2014","journal-title":"Oncotarget"},{"issue":"7 Pt 1","key":"10.1016\/j.bbcan.2020.188432_bb0590","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1440-1746.2008.05308.x","article-title":"Conditionally immortalized colonic epithelial cell line from a Ptk6 null mouse that polarizes and differentiates in vitro","volume":"23","author":"Whitehead","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0595","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbrc.2014.11.057","article-title":"Protein tyrosine kinase 6 mediates TNFalpha-induced endothelial barrier dysfunction","volume":"456","author":"Haines","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.bbcan.2020.188432_bb0600","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.4161\/cc.4.9.1965","article-title":"The intracellular tyrosine kinase Brk sensitizes non-transformed cells to inducers of apoptosis","volume":"4","author":"Haegebarth","year":"2005","journal-title":"Cell Cycle"},{"issue":"7","key":"10.1016\/j.bbcan.2020.188432_bb0605","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/sj.onc.1201241","article-title":"BRK tyrosine kinase expression in a high proportion of human breast carcinomas","volume":"15","author":"Barker","year":"1997","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bbcan.2020.188432_bb0610","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/path.1720","article-title":"Simultaneous over-expression of the Her2\/neu and PTK6 tyrosine kinases in archival invasive ductal breast carcinomas","volume":"205","author":"Born","year":"2005","journal-title":"J. Pathol."},{"issue":"6","key":"10.1016\/j.bbcan.2020.188432_bb0615","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1158\/0008-5472.CAN-15-2510","article-title":"Breast tumor kinase (Brk\/PTK6) is induced by HIF, glucocorticoid receptor, and PELP1-mediated stress Signaling in triple-negative breast cancer","volume":"76","author":"Regan Anderson","year":"2016","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0620","first-page":"39","article-title":"Tracing the footprints of the breast cancer oncogene BRK \u2013 past till present","volume":"1856","author":"Goel","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.bbcan.2020.188432_bb0625","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.coph.2010.08.007","article-title":"Brk\/PTK6 signaling in normal and cancer cell models","volume":"10","author":"Ostrander","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"issue":"15","key":"10.1016\/j.bbcan.2020.188432_bb0630","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1158\/0008-5472.CAN-15-3445","article-title":"PTK6 inhibition suppresses metastases of triple negative breast cancer via snail-dependent E-cadherin regulation","volume":"76","author":"Ito","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2020.188432_bb0635","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13058-015-0594-z","article-title":"PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim","volume":"17","author":"Park","year":"2015","journal-title":"Breast Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188432_bb0640","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.2353\/ajpath.2009.080811","article-title":"Brk protects breast cancer cells from autophagic cell death induced by loss of anchorage","volume":"175","author":"Harvey","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2020.188432_bb0645","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2013.43","article-title":"Protein tyrosine kinase 6 regulates mammary gland tumorigenesis in mouse models","volume":"2","author":"Peng","year":"2013","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0650","first-page":"1","article-title":"Protein tyrosine kinase 6 signaling in prostate cancer","volume":"8","author":"Alwanian","year":"2020","journal-title":"Am. J. Clin. Exp. Urol."},{"issue":"12","key":"10.1016\/j.bbcan.2020.188432_bb0655","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12032-014-0317-9","article-title":"Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma","volume":"31","author":"Chen","year":"2014","journal-title":"Med. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188432_bb0660","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.06.007","article-title":"Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma","volume":"143","author":"Ma","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2020.188432_bb0665","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1479-5876-11-59","article-title":"Low expression of PTK6\/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma","volume":"11","author":"Liu","year":"2013","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188432_bb0670","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.bbrc.2018.07.051","article-title":"Decreased expression of protein tyrosine kinase 6 contributes to tumor progression and metastasis in laryngeal squamous cell carcinoma","volume":"503","author":"Wu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bbcan.2020.188432_bb0675","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s13277-011-0188-z","article-title":"Detection of Brk expression in non-small cell lung cancer: clinicopathological relevance","volume":"32","author":"Fan","year":"2011","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbcan.2020.188432_bb0680","first-page":"183","article-title":"Expression of protein tyrosine kinase 6 (PTK6) in nonsmall cell lung cancer and their clinical and prognostic significance","volume":"6","author":"Zhao","year":"2013","journal-title":"Onco Targets Ther."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188432_bb0685","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archotol.130.3.311","article-title":"Identification of tyrosine kinases overexpressed in head and neck cancer","volume":"130","author":"Lin","year":"2004","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188432_bb0690","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bbrc.2012.04.034","article-title":"Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive cancers","volume":"421","author":"Cho","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bbcan.2020.188432_bb0695","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096060","article-title":"PTK6 promotes cancer migration and invasion in pancreatic cancer cells dependent on ERK signaling","volume":"9","author":"Ono","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.bbcan.2020.188432_bb0700","first-page":"4354","article-title":"PTK6 promotes hepatocellular carcinoma cell proliferation and invasion","volume":"8","author":"Chen","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0705","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40880-016-0114-2","article-title":"The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer","volume":"35","author":"Wang","year":"2016","journal-title":"Chin. J. Cancer"},{"issue":"17","key":"10.1016\/j.bbcan.2020.188432_bb0710","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.7150\/jca.21318","article-title":"Overexpression of PTK6 predicts poor prognosis in bladder cancer patients","volume":"8","author":"Xu","year":"2017","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2020.188432_bb0715","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1158\/1541-7786.MCR-07-2001","article-title":"BRAF silencing by short hairpin RNA or chemical blockade by PLX4032 leads to different responses in melanoma and thyroid carcinoma cells","volume":"6","author":"Sala","year":"2008","journal-title":"Mol. Cancer Res. MCR"},{"issue":"8","key":"10.1016\/j.bbcan.2020.188432_bb0720","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1073\/pnas.0711741105","article-title":"Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity","volume":"105","author":"Tsai","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2020.188432_bb0725","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00969","article-title":"BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling","volume":"2","author":"Vin","year":"2013","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0730","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1158\/0008-5472.CAN-16-1038","article-title":"Targeting BRK-positive breast cancers with small-molecule kinase inhibitors","volume":"77","author":"Jiang","year":"2017","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2020.188432_bb0735","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198374","article-title":"Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers","volume":"13","author":"Qiu","year":"2018","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.bbcan.2020.188432_bb0740","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1182\/blood-2007-07-102061","article-title":"Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets","volume":"110","author":"Rix","year":"2007","journal-title":"Blood"},{"issue":"27","key":"10.1016\/j.bbcan.2020.188432_bb0745","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1021\/jm049486a","article-title":"Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src\/Abl kinase inhibitor with potent antitumor activity in preclinical assays","volume":"47","author":"Lombardo","year":"2004","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bbcan.2020.188432_bb0750","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nchembio.332","article-title":"A chemical and phosphoproteomic characterization of dasatinib action in lung cancer","volume":"6","author":"Li","year":"2010","journal-title":"Nat. Chem. Biol."},{"issue":"11","key":"10.1016\/j.bbcan.2020.188432_bb0755","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nbt.2017","article-title":"Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity","volume":"29","author":"Anastassiadis","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"11","key":"10.1016\/j.bbcan.2020.188432_bb0760","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1158\/0008-5472.CAN-05-4187","article-title":"The structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants","volume":"66","author":"Tokarski","year":"2006","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2020.188432_bb0765","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1747-0285.2011.01230.x","article-title":"X-ray crystal structure of bone marrow kinase in the x chromosome: a Tec family kinase","volume":"78","author":"Muckelbauer","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188432_bb0770","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/pro.321","article-title":"Structures of human Bruton\u2019s tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases","volume":"19","author":"Marcotte","year":"2010","journal-title":"Protein Sci."},{"issue":"19","key":"10.1016\/j.bbcan.2020.188432_bb0775","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1016\/j.bmcl.2011.07.101","article-title":"Discovery of novel imidazo[1,2-a]pyrazin-8-amines as Brk\/PTK6 inhibitors","volume":"21","author":"Zeng","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"19","key":"10.1016\/j.bbcan.2020.188432_bb0780","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1016\/j.bmcl.2014.08.036","article-title":"Discovery of (E)-5-(benzylideneamino)-1H-benzo[d]imidazol-2(3H)-one derivatives as inhibitors for PTK6","volume":"24","author":"Shim","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188432_bb0785","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3892\/ol.2017.5564","article-title":"The associated pyrazolopyrimidines PP1 and PP2 inhibit protein tyrosine kinase 6 activity and suppress breast cancer cell proliferation","volume":"13","author":"Shim","year":"2017","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.bbcan.2020.188432_bb0790","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040531","article-title":"Hwanggeumchal sorghum induces cell cycle arrest, and suppresses tumor growth and metastasis through Jak2\/STAT pathways in breast cancer xenografts","volume":"7","author":"Park","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bbcan.2020.188432_bb0795","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.bmcl.2014.03.002","article-title":"Discovery of 4-anilino alpha-carbolines as novel Brk inhibitors","volume":"24","author":"Mahmoud","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.bbcan.2020.188432_bb0800","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.5414\/CPXCES14EA07","article-title":"Novel 4-anilino-alpha-carboline derivatives induce cell death in nonadhesive breast cancer cells through inhibition of Brk activity","volume":"53","author":"Oelze","year":"2015","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188432_bb0805","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/cmdc.201200516","article-title":"Optimization of marine triterpene sipholenols as inhibitors of breast cancer migration and invasion","volume":"8","author":"Foudah","year":"2013","journal-title":"ChemMedChem"},{"issue":"28","key":"10.1016\/j.bbcan.2020.188432_bb0810","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1039\/C4OB00553H","article-title":"Marine natural products-inspired phenylmethylene hydantoins with potent in vitro and in vivo antitumor activities via suppression of Brk and FAK signaling","volume":"12","author":"Sallam","year":"2014","journal-title":"Org. Biomol. Chem."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188432_bb0815","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/cbdd.12380","article-title":"Discovery, optimization, and pharmacophore modeling of oleanolic acid and analogues as breast cancer cell migration and invasion inhibitors through targeting Brk\/Paxillin\/Rac1 axis","volume":"85","author":"Elsayed","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188432_bb0820","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1021\/acs.jproteome.6b00576","article-title":"Deep Phosphotyrosine proteomics by optimization of phosphotyrosine enrichment and MS\/MS parameters","volume":"16","author":"Abe","year":"2017","journal-title":"J. Proteome Res."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188432_bb0825","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.celrep.2015.03.037","article-title":"Inhibition of Lapatinib-induced Kinome reprogramming in ERBB2-positive breast cancer by targeting BET family Bromodomains","volume":"11","author":"Stuhlmiller","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2020.188432_bb0830","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bay119","article-title":"Ensembl variation resources","author":"Hunt","year":"2018","journal-title":"Database (Oxford) 2018"},{"issue":"2","key":"10.1016\/j.bbcan.2020.188432_bb0835","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/cr.2009.6","article-title":"DOG 1.0: illustrator of protein domain structures","volume":"19","author":"Ren","year":"2009","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188432_bb0840","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/pro.3290","article-title":"Clustal omega for making accurate alignments of many protein sequences","volume":"27","author":"Sievers","year":"2018","journal-title":"Protein Sci."},{"issue":"9","key":"10.1016\/j.bbcan.2020.188432_bb0845","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","article-title":"Jalview version 2--a multiple sequence alignment editor and analysis workbench","volume":"25","author":"Waterhouse","year":"2009","journal-title":"Bioinformatics"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X20301517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X20301517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:42:58Z","timestamp":1759639378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X20301517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":169,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0304419X20301517"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2020.188432","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting protein tyrosine kinase 6 in cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2020.188432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"188432"}}